Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biotech & Life Science Fund A/S
A/S
Active
CVR 42582557
Kongevejen 365, 2840
Holte
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2021
— employees
Watchlist
Share
Denmark
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Biotech & Life Science Fund A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
-70
-230
-203
-175
-163
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-70
-230
-203
-175
-163
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-70
-230
-203
-175
-163
Net financials
-389
-822
84
-434
810
Profit before tax
-459
-1.052
-119
-609
647
Tax
-0
-0
-0
-0
-0
Net profit
-459
-1.052
-119
-609
647
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
10.357
12.074
10.710
8.503
7.896
Equity
10.332
12.014
10.651
8.447
7.827
Long-term debt
0
0
0
0
0
Short-term debt
25
60
59
57
69
Total debt
25
60
59
57
69
Financial ratios
5-year trend
EBITDA margin
-16300700.0%
This company
15.8%
Market median
-103169087% vs market
2021
2025
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
2021
2025
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
2021
2025
Net profit margin
64658400.0%
This company
8.1%
Market median
+798251752% vs market
2021
2025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-08-03 – 2021-12-31
View
PDF
More on Biotech & Life Science Fund A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
